PAPADOPOULOS STELIOS

Insider Buys Quantity –
12
2024-05-20SaleExelixis, Inc.
EXEL
director
11,437
0.0039%
$21.00$240,177+3.27%
2022-02-22SaleExelixis, Inc.
EXEL
director
84,515
0.0264%
$19.56$1.65M-8.62%
2021-05-11SaleExelixis, Inc.
EXEL
director
20,770
0.0067%
$24.98$518,794-20.62%
2020-05-08SaleExelixis, Inc.
EXEL
director
45,000
0.0145%
$25.84$1.16M-12.27%
2019-05-07PurchaseRegulus Therapeutics Inc.
RGLS
director
370,370
1.9953%
$1.08$400,000-40%
2019-02-21SaleExelixis, Inc.
EXEL
director
26,250
0.0087%
$21.25$557,813-6.83%
2018-12-28PurchaseRegulus Therapeutics Inc.
RGLS
director
50,000
0.569%
$1.09$54,570-12.73%
2018-12-27PurchaseRegulus Therapeutics Inc.
RGLS
director
26,401
0.2916%
$1.04$27,460-10.65%
2018-12-26PurchaseRegulus Therapeutics Inc.
RGLS
director
90,000
0.9471%
$0.95$85,878-6.73%
2018-11-16PurchaseRegulus Therapeutics Inc.
RGLS
director
300,000
3.3093%
$1.38$415,470-27.78%
2018-11-15PurchaseRegulus Therapeutics Inc.
RGLS
director
200,000
2.3033%
$1.33$265,080-21.21%
2018-05-07SaleExelixis, Inc.
EXEL
director
15,000
0.005%
$22.15$332,250-7.11%
2018-03-02SaleExelixis, Inc.
EXEL
director
15,000
0.0051%
$24.05$360,750-14.02%
2017-09-22SaleExelixis, Inc.
EXEL
director
10,000
0.0035%
$25.40$254,000-7.19%
2017-09-19SaleExelixis, Inc.
EXEL
director
127,790
0.043%
$27.63$3.53M-16.35%
2017-09-18SaleExelixis, Inc.
EXEL
director
72,210
0.0247%
$27.76$2M-14.88%
2017-07-25PurchaseRegulus Therapeutics Inc.
RGLS
director
1M
0.9102%
$0.91$910,000-17.12%
2017-03-22PurchaseRegulus Therapeutics Inc.
RGLS
director
300,000
0.5557%
$1.23$368,100-8.8%
2017-03-21PurchaseRegulus Therapeutics Inc.
RGLS
director
200,000
0.3771%
$1.20$239,800-4.17%
2017-03-20SaleExelixis, Inc.
EXEL
director
10,000
0.0034%
$21.66$216,600+18.19%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us